We need more useful surrogate markers for the efficacy of beta-blockers for the treatment of Takotsubo cardiomyopathy.
Hiroaki KawanoToshihiko YamasaShuji ArakawaYuji MatsumotoOsami SatoKoji MaemuraPublished in: Geriatrics & gerontology international (2019)